-
Two Years Into the Coronavirus Pandemic, Fauci Hopes the World Will Not Forget Lessons From a ‘Catastrophic Experience'
Two years after the World Health Organization declared the coronavirus a pandemic, public health experts warn not to become complacent.
-
What to Watch Today: Wall Street Set to Open Higher, Breaking a Multiday Losing Streak
U.S. stock futures bounced Wednesday after the S&P 500 closed in correction territory.
-
Stocks Making the Biggest Moves Premarket: Lowe's, Tenneco, Tupperware and Others
These are the stocks posting the largest moves before the bell.
-
Stocks Making the Biggest Moves Midday: Under Armour, Zillow, Affirm and More
These are the stocks posting the largest moves in midday trading.
-
What to Watch Today: Dow Futures Decline After Strong Jobs Report
Dow futures fell and the 10-year Treasury yield rose after Friday’s jobs report showed strong gains last month.
-
Stocks Making the Biggest Moves Premarket: Amazon, Snap, Ford and More
These are the stocks posting the largest moves before the bell.
-
Cramer's Week Ahead: Have Your Buy List Ready for Any ‘Hideous Moments'
CNBC’s Jim Cramer on Friday previewed next week’s major corporate earnings reports.
-
Big Swings in the Market Are More Normal Than Investors Might Expect, But Things Could Get Worse
The stock market’s wild gyrations have been an emotional roller coaster for investors, and the ride has not come to a full stop.
-
What Jim Cramer Is Watching Wednesday — Our Favorite Economic Recovery Play
Jim’s thoughts on Union Pacific, Chevron and more.
-
What Jim Cramer Is Watching Monday — Our Investing Mantra for 2022
Jim’s thoughts on Tesla, Apple, bank stocks and more…
-
Dow Notches 5-Day Winning Streak, S&P 500 Dips From Record as Investors Weigh Omicron
U.S. stocks were mixed Tuesday as the major stock indexes looked to build on record highs in the final week of the year.
-
Omicron May Sideline Two Leading Drugs Against COVID-19
The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they’ve used to fight COVID-19
-
Regeneron Developing Antibodies to Target Omicron as Current Cocktail Loses Potency Against Variant
CEO Leonard Schleifer told CNBC Regeneron plans to conduct trials on the new antibodies in the first quarter of 2022.
-
What to Watch Today: S&P 500 Set for Record at Open in a Relief Rally After Fed's Decision
Dow futures jumped Thursday, pointing to a continued surge as investors seemed satisfied with the Fed’s accelerated tightening plans.
-
5 Things to Know Before the Stock Market Opens Thursday
Dow futures jumped Thursday, pointing to a continued surge as investors seemed satisfied with the Fed’s accelerated tightening plans.
-
Stocks Making the Biggest Moves Premarket: Delta Air Lines, Accenture, Regeneron and Others
These are the stocks posting the largest moves before the bell.
-
Stocks Making the Biggest Moves Midday: Medtronic, Roku, Bloomin' Brands, CMC Materials and More
These are the stocks posting the largest moves in midday trading.
-
What to Watch Today: Wall Street Looks Steady Ahead of Expected Fed Pivot
U.S. stocks futures pointed to a steady open ahead of the Fed’s widely expected afternoon announcement of a faster tapering.
-
Stocks Making the Biggest Moves Premarket: Toyota, Vir Biotechnology, Eli Lilly and Others
These are the stocks posting the largest moves before the bell.
-
Cramer's Week Ahead: Focus Is on the Fed, Which Should Speed Up Timeline of Rate Hikes
It’s clear the Fed’s emergency policy stance is “untenable” after Friday’s consumer price index report, CNBC’s Jim Cramer said.
Trending
